Standalone total income for the quarter under review grew to Rs 2,470.69 crore from Rs 2,439.78 crore registered in the same period last fiscal.
The market valuation of Reliance Industries Ltd (RIL) declined by Rs 56,741.2 crore to reach Rs 16,09,686.75 crore.
Total expenses of IFB Industries were at Rs 957.89 crore as compared with Rs 689.06 crore.
During the July-September period, total consolidated income also increased to Rs 1,277.03 crore, from Rs 967.49 crore in the corresponding quarter of the previous fiscal, GPIL said in a regulatory filing.
Many Indians may have become crorepatis at least on paper due to Shiba Inu, say industry trackers
BSE Sensex settled below the 60,000 mark on Friday, whereas Nifty50, somehow, managed to hold 17,650 level. However, the broader market outperformed the benchmark indices despite heavy selling.
“India has been a great performing market compared to all emerging markets and I think compared to developed markets too. â€
"In India nobody gets excited with 7% to 8% growth. Any company that does not grow double digit does not excite investors here but in the case of IT services, 7% to 8% dollar growth would very logically translate into low double digits or low teens rupee growth."
The IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list before the end of the current financial year.
During the year ended March 31, 2021, the company had entered into a transaction for the sale of investments of Rs 1,407 crore with Hindustan Zinc as part of its treasury operations, for which prior approval from the audit committee as stipulated under listing regulations was not taken.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.